Skip to content

Clinical trials

Intellectual Disability trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Intellectual Disability Country / region: Canada Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20162
20181
20191
20221
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Centre for Addiction and Mental Health2
Dr. Jessica Jones1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Hsiang-Yuan Lin1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
National Institute of Mental Health (NIMH)1
Taysha Gene Therapies, Inc.1
The George Institute1
Ultragenyx Pharmaceutical Inc1
University of Alberta1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Intellectual Disability12
Nervous System Diseases4
Developmental Disabilities3
Genetic Diseases, X-Linked3
Learning Disabilities3
X-Linked Intellectual Disability3
Chromosome Disorders2
Congenital Abnormalities2
Fragile X Syndrome2
Neurobehavioral Manifestations2

Trials

Showing 51 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.